Menu Close

CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018

SHANGHAI, Dec. 4, 2018 /PRNewswire/ — CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, presented initial safety and efficacy results from its ongoing investigational study of … (본문 전체 12/4/2018 8:00 PM)